Abstract:Abstract Aims/hypothesis Pancreatic beta cells are subjected to exogenous damaging factors such as proinflammatory cytokines or excess glucose that can cause accumulation of damage-inducing reactive oxygen species during the pathogenesis of diabetes. We and others have shown that beta cell autophagy can reduce reactive oxygen species to protect against apoptosis. While impaired islet autophagy has been demonstrated in human type 2 diabetes, it is unknown if islet autophagy is perturbed in the pathogenesis of type 1 diabetes. We hypothesised that beta cell autophagy is dysfunctional in type 1 diabetes, and that there is a progressive loss during early diabetes development. Methods Pancreases were collected from chloroquine-injected and non-injected non-obese diabetes-resistant (NOR) and non-obese diabetic (NOD) mice. Age- and BMI-matched pancreas tissue sections from human organ donors ( N = 34) were obtained from the Network for Pancreatic Organ Donors with Diabetes (nPOD). Tissue sections were stained with antibodies against proinsulin or insulin (beta cell markers), microtubule-associated protein 1 light chain 3 A/B (LC3A/B; autophagosome marker), lysosomal-associated membrane protein 1 (LAMP1; lysosome marker) and p62 (autophagy adaptor). Images collected on a scanning laser confocal microscope were analysed with CellProfiler and ImageJ. Secondary lysosomes and telolysosomes were assessed in electron micrographs of human pancreatic tissue sections ( n = 12), and energy dispersive x-ray analysis was performed to assess distribution of elements ( n = 5). Results We observed increased autophagosome numbers in islets of diabetic NOD mice ( p = 0.008) and increased p62 in islets of both non-diabetic and diabetic NOD mice ( p < 0.001) vs NOR mice. There was also a reduction in LC3–LAMP1 colocalisation in islets of diabetic NOD mice compared with both non-diabetic NOD ( p < 0.001) and NOR mice ( p < 0.001). Chloroquine elicited accumulation of autophagosomes in the islets of NOR ( p = 0.003) and non-diabetic NOD mice ( p < 0.001), but not in islets of diabetic NOD mice; and stimulated accumulation of p62 in NOR ( p < 0.001), but not in NOD mice. We observed reduced LC3–LAMP1 colocalisation ( p < 0.001) in residual beta cells of human donors with type 1 diabetes vs non-diabetic participants. We also observed reduced colocalisation of proinsulin with LAMP1 in donors with type 1 diabetes ( p < 0.001). Electron microscopy also revealed accumulation of telolysosomes with nitrogen-dense rings in beta cells of autoantibody-positive donors ( p = 0.002). Conclusions/interpretation We provide evidence of islet macroautophagy/crinophagy impairment in human type 1 diabetes. We also document accumulation of telolysosomes with peripheral nitrogen in beta cells of autoantibody-positive donors, demonstrating altered lysosome content that may be associated with lysosome dysfunction before clinical hyperglycaemia. Similar macroautophagy impairments are present in the NOD mouse model of type 1 diabetes. Graphical abstract

Defective Insulin Maturation in Patients with Type 2 Diabetes

Misfolded Proinsulin Impairs Processing of Precursor of Insulin Receptor and Insulin Signaling in Β Cells.

Proinsulin Misfolding and Endoplasmic Reticulum Stress During the Development and Progression of Diabetes☆

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

Structural And Functional Abnormalities In The Islets Isolated From Type 2 Diabetic Subjects

Increased Frequency of Β Cells with Abnormal NKX6.1 Expression in Type 2 Diabetes but Not in Subjects with Higher Risk for Type 2 Diabetes

Heterogeneity and altered β-cell identity in the TallyHo model of early-onset type 2 diabetes

Normal And Defective Pathways In Biogenesis And Maintenance Of The Insulin Storage Pool

Pancreatic Beta-cell Dysfunction in Type 2 Diabetes

Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes

Restoration of PITPNA in Type 2 diabetic human islets reverses pancreatic beta-cell dysfunction

Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanism

The Impairment of Glucose-Stimulated Insulin Secretion in Pancreatic Β-Cells Caused by Prolonged Glucotoxicity and Lipotoxicity is Associated with Elevated Adaptive Antioxidant Response.

[Role of Insulin Resistance and Β Cell Function in the Development of Newly Diagnosed Type 2 Diabetes].

Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes

187-OR: Declines in ß-Cell Glucose Responsiveness Correlate with Loss of Glucose Metabolism during T1D Pathogenesis

ER redox homeostasis regulates proinsulin trafficking and insulin granule formation in the pancreatic islet β-cell

Pancreatic beta cell autophagy is impaired in type 1 diabetes